Everything tagged "robotics" across the TickerSpark archives.
Stryker’s Q2 execution, Mako robotics momentum, and raised full-year outlook support a Buy, though valuation leaves limited room for error. Cybersecurity, supply disruption, and tariff pressure keep the risk profile disciplined.
Intuitive Surgical continues to compound through rising procedures, a larger installed base, and an increasingly recurring revenue mix. The main debate is whether that quality justifies the stock’s premium valuation.
Teradyne’s Q1 2026 results showed record revenue, AI-driven demand, and a sharply higher earnings profile. The stock looks attractive as an AI infrastructure enabler, but valuation keeps the rating at Hold.
Symbotic’s selloff on insider-sale headlines looks smaller than the business inflection underneath it. The latest quarter showed real operating leverage, positive net income, and a $2.0 billion cash pile that gives SYM room to keep scaling.
Symbotic is scaling quickly with $22.7B of backlog, 23% Q2 revenue growth, and improving profitability, but its premium valuation and heavy customer concentration keep the stock in Hold territory.
Seven robotics stocks are ranked from speculative delivery and warehouse names to more profitable automation enablers in this August 2026 countdown.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime